CN1144591C - Application of Sichuan champion bauhinia saponin in preparing anti-tumor medicine - Google Patents

Application of Sichuan champion bauhinia saponin in preparing anti-tumor medicine Download PDF

Info

Publication number
CN1144591C
CN1144591C CNB991157311A CN99115731A CN1144591C CN 1144591 C CN1144591 C CN 1144591C CN B991157311 A CNB991157311 A CN B991157311A CN 99115731 A CN99115731 A CN 99115731A CN 1144591 C CN1144591 C CN 1144591C
Authority
CN
China
Prior art keywords
saponin
sichuan
champion bauhinia
application
river
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB991157311A
Other languages
Chinese (zh)
Other versions
CN1266687A (en
Inventor
王晓娟
朱玲珍
王四旺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fourth Military Medical University FMMU
Original Assignee
Fourth Military Medical University FMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fourth Military Medical University FMMU filed Critical Fourth Military Medical University FMMU
Priority to CNB991157311A priority Critical patent/CN1144591C/en
Publication of CN1266687A publication Critical patent/CN1266687A/en
Application granted granted Critical
Publication of CN1144591C publication Critical patent/CN1144591C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an application of a Sichuan champion bauhinia saponin in preparing anti-tumor medicine, and a compound extracted from plants. Sichuan champion bauhinia is used as a raw material to which a series of extraction methods of alcohol extraction, pressure reducing concentration, extraction, low pressure chromatography, elution, etc. are carried out so that a crystal compound, namely the Sichuan champion bauhinia saponin is obtained. Experiments prove that the Sichuan champion bauhinia saponin has inhibiting effect on the gene replication of tumor cells, and the dose of oral administration LD50 is about 12 times of the least effective dose, which indicate that the saponin has high safety and is worth further developing.

Description

The application of ardipusilloside as the preparation antitumor drug produced in the river
Technical field
The chemical compound that the present invention relates to extract from plant is used to prepare the application of antitumor drug.
Background technology
It is the herb of Myrsinacea Ardisa plant that A.pusilla A.DC. (Ardisea pusilla A.DC) is produced in the river, and the effect of heat-clearing and toxic substances removing, reducing swelling and alleviating pain is arranged, the traumatic injury that is used among the people, and promoting blood circulation to remove obstruction in the collateral also can be used for venom.Producing the chemical compound-river product ardipusilloside that extracts the A.pusilla A.DC. from the river is used to prepare antitumor drug, does not appear in the newspapers as yet both at home and abroad.
Summary of the invention
The objective of the invention is to produce the chemical compound-river that extracts the A.pusilla A.DC. and produce ardipusilloside, be used to prepare anti-tumor drug from the river.
Technology implementation scheme of the present invention: with 95% ethanol extraction A.pusilla A.DC. herb coarse powder, concentrating under reduced pressure gets extractum, after adding water and stirring, leave standstill filtration, filtrate extracts in turn with petroleum ether, ether, ethyl acetate and n-butyl alcohol, with the extract acetone precipitation, through the silica gel low pressure column chromatography, solubilizer CHCl 3-MeOH-H 2O (65: 35: 10, lower floor) eluting gets crystalline compounds, and its molecular formula is:
3-O-[α-L-pyrans rhamnose (1 → 2)-β-D-Glucopyranose. (1 → 3)] [β-D-Glucopyranose. (1 → 2)] α-L-arabinose-quick A of Xi carat;
Its structural formula is:
Figure C9911573100031
The present invention can be used for preparing the medicine that suppresses hepatocarcinoma, pulmonary carcinoma, gastric cancer, ovarian cancer, cervical cancer, the esophageal carcinoma and renal carcinoma.
In detail, the present invention is the ethanol extraction A.pusilla A.DC. herb coarse powder with 95%, and concentrating under reduced pressure gets extractum, after adding the water stirring, leave standstill filtration, filtrate extracts in turn with petroleum ether, ether, ethyl acetate and n-butyl alcohol, with the extract acetone precipitation, through the silica gel low pressure column chromatography, solubilizer CHCL 3-MeOH-H 2O (65: 35: 10, lower floor) eluting gets crystalline compounds.Chemical compound is white needle, and mp239-241 ℃, infrared spectrum shows hydroxyl (3423cm -1), aldehyde radical (2700 and 1716cm -1) and cyclic ethers (1075 and 1044cm -1).Mass spectrum m/z:1097 (M+Na) +, molecular weight 1074 is C in conjunction with elemental analysis molecular formula 53H 86O 22.2H 2O.Chemical compound 13C nuclear magnetic resoance spectrum δ: 101.7,104.4,105.3 and the 103.2ppm signal, its acetylate 1The H nuclear magnetic resoance spectrum has 11 acetyl group signals; all show to have four glycosyls in the chemical compound, chemical compound is used the acid vapour hydrolysis on the high-efficient silica gel lamellae, detect D-glucose, L-arabinose and L-rhamnose; scan to such an extent that each sugared ratio is 2: 1: 1 through thin, chemical compound 13C nuclear magnetic resoance spectrum δ C-389.1ppm move 11.0ppm, δ to low field than glycoside unit C-226.6ppm move 1.7ppm (table 1) than glycoside unit to High-Field, the C of sugar chain and glycoside unit be described 3-OH is connected.The important information m/:1097 (M+Na) that mass spectrum has pointed out sugar chain to connect +, 951 (M+Na-146) +, 935 (M+Na-162) +, 626 (glycoside unit+Na+132) +, show that sugar chain is branched.The mass spectrum m/z:273 of the acetylate of chemical compound (acetyl rhamnose), 331 (acetyl glucosamines), 561 (acetyl rhamnose-acetyl glucosamine).The fractional hydrolysis of chemical compound test detects each sucrose solution and separates order and be rhamnose, glucose and arabinose, more than show that all the sugared order of connection is that a glucose links to each other with arabinose with a rhamnose Fructus Vitis viniferae disaccharidase simultaneously.By chemical compound 13C- 1Anomeric proton (1-H) signal of four glycosyls of the relevant spectrum of H appears at respectively: δ: 6.39,5.37,5.21 and 4.94ppm, the proton signal of each glycosyl overlaps each other in δ: 3.8-4.7 spectrum district, be difficult to determine its ownership with conventional method, then adopted the relevant spectrum of one-dimensional multi relay new method to do research, whole proton signals of each glycosyl can be separated and identify to this method from the spectrum peak that highly overlaps, each glycosyl proton chemical shifts and coupling constant are summarized in table 2.By each sugared end group carbon 13C nuclear magnetic resonance, NMR spectrum signal has been determined the configuration that each is sugared, and glucose is β-D-type, and rhamnose and arabinose are α-L-type, again in conjunction with the (irradiation of NOE difference spectrum 1H nuclear makes with its coupling 13It is NOE effect or NOE difference spectrum that the effect that the signal intensity of C nuclear increases is called this effect of nuclear furan person of outstanding talent difficult to understand) 1-H of each glycosyl of selective exitation, observe the NOE gain signal, contrast with one-dimensional multi relay spectrum again, these MOE gain signals are belonged to (seeing Table 3).According to MOE effect and nuclear separation relation, thereby the structure that determines sugar chain is:
Table 1 glycoside unit molecule in deuterated pyridine solution 13The C chemical shift
C ardipusilloside cycalamin A C ardipusilloside cycalamin A
1 39.6 39.5 16 76.9 76.8
2 26.6 28.3 17 48.3 48.2
3 89.1 78.1 18 50.4 50.6
4 39.2 39.5 19 24.2 24.1
5 55.6 55.7 20 36.9 37.3
6 18.0 18.2 21 36.8 36.8
7 32.7 32.7 22 32.4 32.3
8 44.1 44.0 23 28.1 28.6
9 53.4 53.3 24 16.4 16.3
10 42.6 42.6 25 16.5 16.5
11 19.2 19.2 26 19.8 19.8
12 30.5 30.7 27 18.6 18.6
13 86.5 86.4 28 77.7 77.7
14 44.6 44.6 29 24.4 4.1
15 33.4 33.4 30 207.9 207.3
Table 2 is glycan molecule proton chemical shifts value and coupling constant in deuterated pyridine solution
Proton Chemical displacement value δ (ppm) Coupling constant J (Hz) Proton Chemical displacement value δ (ppm) Coupling constant J (Hz)
Rham rhamnose 123456 (CH 3) Glu-2 glucose-2 12345 6a 6b 6.39bs 4.75bs 4.71dd 4.32t 5.04m 1.79d 5.21d 4.27t 4.21t 4.12t 3.34m 4.50d 4.31dd 3.7,9.4 9.4,9.4 9.4,6.1 6.1 8.4 8.4,8.4 8.4,8.5 8.5,8.4 8.4,5.3 9.8 9.8,5.3 Glu-2 glucose-1 12345 6a 6b Ara arabinose 1234 5a 5b 5.37d 4.09t 4.36t 4.28t 4.05m 4.51d 4.40dd 4.94bd 4.59m 4.51m 4.40m 4.40m 3.82d 8.7 8.7,8.7 8.7,8.6 8.6,8.7 8.7,4.4 9.4 9.4,4.5
The NOE value of table 3 glycan molecule in deuterated pyridine solution
According to the time NOE value added
Proton Chemical displacement value Belong to NOE(%)
Arabinose rhamnose glucose 2 glucoses 1 3.12(dd) 4.27(t) 4.51(m) 4.59(m) Glycoside unit-H 3Glucose 2-H 2Arabinose-H 3Arabinose-H 2 18.9 11.1 8.1 10.2
Cancerous cell differentiation-inducing action-the mtt assay of ardipusilloside to In vitro culture produced in the river: its principle is that tetrazolium blue chemical compound MTT (Methylthiazolyltertrazolium) cleavable under the effect of living cells line liquid enzymes is the insoluble first chemical compound of purple, measure its optical density variation with microplate reader after adding dimethyl sulfoxide, can obtain the oncocyte number change of cancer therapy drug effect, obtain the survival rate of cell with this, according to the median lethal dose(LD 50) (ID of tumor cell 50) judge the sensitivity of tumor cell to anticarcinogen.Hepatocarcinoma (SMMC-7721), hepatocarcinoma (HCC-9204), pulmonary carcinoma (A549), gastric cancer (SGC-7901), ovarian cancer (HO-8910), cervical cancer (Hela), the esophageal carcinoma (Eca-109), 8 kinds of human tumor cells of renal carcinoma (GRC-1) are made single cell suspension, in 96 empty plane culture plates, cell (5 * 10 4/ ml) and after the river produces the ardipusilloside aqueous solution and cultivate 72h together, add MTT20ul, continue to cultivate 4h, centrifugal, abandon supernatant, add 150 μ l dimethyl sulphoxide solutions precipitation, measure OD490.Calculate the formula of cell survival rate:
The result: mtt assay is measured and is shown that river product ardipusilloside all is dosage-effect relation to the inhibitory action of 8 kinds of human tumor cells, increases with drug concentrations, and cell survival rate descends gradually.(seeing Table 4).
Table 4 mtt assay is measured 8 kinds of tumor cell survival rates (%)
Tumor cell Ardipusilloside (μ g/ml) ID 50
1.5625 3.125 6.25 12.5 25 50 (μg/ml)
A549 SGC-7901 Hela GRC-1 SMMC-7721 HCC-9204 HO-8910 Eca-109 84.66 100.8 91.32 94.25 91.91 111.4 85.83 98.26 77.53 90.54 91.32 91.88 79.97 93.63 60.39 92.07 37.36 49.75 15.11 58.26 25.61 33.19 47.19 60.59 34.34 30.81 11.9 43.51 3.98 4.47 10.68 25.52 155.33 28.58 3.22 36.88 2.29 2.13 4.67 16.18 9.25 25.64 3.86 24.34 0.82 1.68 2.9 14.66 4.94 5.80 3.95 8.89 4.12 4.94 4.94 7.57
Advantage of the present invention:
Produce the chemical compound-river of extracting the A.pusilla A.DC. from the river and produce ardipusilloside, it is newfound chemical compound with antitumor drug, experiment shows that this chemical compound all is dose-effect relationship to the inhibitory action of 8 kinds of human tumor cells, increases with drug concentrations, and cell survival rate descends gradually.
Experiment also shows river product ardipusilloside aqueous solution mice LD 50Be respectively iV:10.29 ± 0.84mg/kg, the 95% credible 9.50~11.17mg/kg that is limited to; Ig:666.70 ± 55.82mg/kg, the 95% credible 613.30~724.82mg/kg that is limited to.Compound i v administration LD is described 50Very little, should not be recommended as the clinical administration mode, and oral administration LD 50Be about 12 times of least effective dose (LED), illustrate that the safety of this approach is bigger, be worth further exploitation.
The specific embodiment
A.pusilla A.DC. herb coarse powder 20kg uses 95% ethanol extraction, and concentrating under reduced pressure gets extractum 1785g, adds H 2O leaves standstill filtration after stirring, and filtrate extracts in turn with petroleum ether, ether, ethyl acetate and n-butyl alcohol, and n-butyl alcohol extract gets total Saponin 61g with acetone precipitation, through silica gel low pressure column chromatography, solvent C HCL 3-MeOH-H 2O (65: 35: 10, lower floor) eluting gets crystalline compounds 20g.

Claims (1)

1, the application of ardipusilloside as the preparation antitumor drug produced in the river, it is characterized in that, ethanol extraction A.pusilla A.DC. herb coarse powder with 95%, concentrating under reduced pressure gets extractum, after adding water and stirring, leaves standstill filtration, filtrate extracts in turn with petroleum ether, ether, ethyl acetate and n-butyl alcohol, with the extract acetone precipitation, through the silica gel low pressure column chromatography, solubilizer CHCl 3-MeOH-H 2O, 65: 35: 10, lower floor, eluting gets crystalline compounds, and its molecular formula is:
3-O-[α-L-pyrans rhamnose (1 → 2)-β-D-Glucopyranose. (1 → 3)] [β-D-Glucopyranose. (1 → 2)] α-L-arabinose-quick A of Xi carat;
Its structural formula is:
Figure C9911573100021
Be used to prepare the medicine that suppresses hepatocarcinoma, pulmonary carcinoma, gastric cancer, ovarian cancer, cervical cancer, the esophageal carcinoma or renal carcinoma.
CNB991157311A 1999-03-12 1999-03-12 Application of Sichuan champion bauhinia saponin in preparing anti-tumor medicine Expired - Lifetime CN1144591C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB991157311A CN1144591C (en) 1999-03-12 1999-03-12 Application of Sichuan champion bauhinia saponin in preparing anti-tumor medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB991157311A CN1144591C (en) 1999-03-12 1999-03-12 Application of Sichuan champion bauhinia saponin in preparing anti-tumor medicine

Publications (2)

Publication Number Publication Date
CN1266687A CN1266687A (en) 2000-09-20
CN1144591C true CN1144591C (en) 2004-04-07

Family

ID=5278648

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB991157311A Expired - Lifetime CN1144591C (en) 1999-03-12 1999-03-12 Application of Sichuan champion bauhinia saponin in preparing anti-tumor medicine

Country Status (1)

Country Link
CN (1) CN1144591C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101381391B (en) * 2008-08-04 2011-04-13 中国人民解放军第四军医大学 Triterpene saponins compounds extracted from ardipusilloside
CN101333239B (en) * 2008-08-04 2011-04-13 中国人民解放军第四军医大学 Anti-glioma compounds of triterpenoid saponin extracted from ardipusilloside
CN102603860A (en) * 2011-01-25 2012-07-25 苏州宝泽堂医药科技有限公司 Method for purifying ardipusilloside I

Also Published As

Publication number Publication date
CN1266687A (en) 2000-09-20

Similar Documents

Publication Publication Date Title
Yuan et al. Structural characterization of a low-molecular-weight polysaccharide from Angelica pubescens Maxim. f. biserrata Shan et Yuan root and evaluation of its antioxidant activity
Wang et al. Structural characterization and in vitro antitumor activity of polysaccharides from Zizyphus jujuba cv. Muzao
Ustyuzhanina et al. The structure of a fucosylated chondroitin sulfate from the sea cucumber Cucumaria frondosa
Yang et al. Isolation, purification, structural characterization, and hypoglycemic activity assessment of polysaccharides from Hovenia dulcis (Guai Zao)
Li et al. Structural characterization, antiproliferative and immunoregulatory activities of a polysaccharide from Boletus Leccinum rugosiceps
Luo et al. Characterization and immunological activity of polysaccharides from Ixeris polycephala
Li et al. Isolation and structural characterization of a neutral polysaccharide from the stems of Dendrobium densiflorum
CN102091104B (en) Method for obtaining refined extract from capparis spinosa and application of extract
CN101935359B (en) Liriope muscari baily polysaccharide and preparation method thereof
CN100584856C (en) The purposes of a kind of Hederagenin, its preparation method and preparation antitumor drug thereof
CN114591448A (en) Phellinus igniarius sporophore mannogalactan and preparation and application thereof
CN1144591C (en) Application of Sichuan champion bauhinia saponin in preparing anti-tumor medicine
CN114805624B (en) Cortex moutan polysaccharide and preparation method and application thereof
CN110862463A (en) Preparation of alfalfa root polysaccharide with bioactivity and selenizing modified polysaccharide thereof
CN101333239B (en) Anti-glioma compounds of triterpenoid saponin extracted from ardipusilloside
Wang et al. Purification, characterization and bioactivities of a 4-O-methylglucuronoxylan from Aralia echinocaulis
CN102276754A (en) Organosulfate glucan in hedysarum polybotys saccharide as well as preparation method and application thereof
CN115386013A (en) Laminaria polysaccharide with strong anticoagulant activity and preparation method and application thereof
Wang et al. Structural characterization and anti-oxidant activity of polysaccharide HVP-1 from Volvariella volvacea
CN114409818A (en) Preparation method and application of physalis pubescens polysaccharide selenide
CN113831314A (en) Preparation method of 2- (R) -hesperetin
CN116120475B (en) Raspberry homogeneous polysaccharide RCP-90-1, and separation and purification method and application thereof as antitumor drug
CN112110967B (en) Luteolin-4 '-O- (6' -O-acetyl) -beta-D glucoside and preparation method and application thereof
CN1309133A (en) Neotoralactone, its derivatives and their application in reducing fat and lossing weight
JPH09176206A (en) Composite polysaccharide extracted from mycobacterium tuberculosis and its manufacture

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: The Fourth Military Medical University of the Chinese People's Liberation Army

Document name: Notice of publication of application for patent for invention

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: The Fourth Military Medical University of the Chinese People's Liberation Army

Document name: Deemed as a notice of withdrawal

C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20040407

CX01 Expiry of patent term